Physician profile

Tracy L Cannon-Smith

Urogynecology and Reconstructive Pelvic Surgery (Urology) · Arlington, TX

NPI 1942297569

$28,878.88

in general payments reported to CMS, 2019-2025

40 companies · $1,394 in 2025

The $1,394 reported for 2025 was more than what a typical Urogynecology and Reconstructive Pelvic Surgery (Urology) provider received nationally (typical 2025 total: $782).

See the full distribution for Urogynecology and Reconstructive Pelvic Surgery (Urology)

Payments by year

General and research payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$4,584.30
Travel and Lodging$2,997.71
Grant$113.64
Gift$76.96

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Caldera Medical, INC $9,417.85 2019-2023 Desara
Axonics, INC. $6,084.80 2021-2024 Axonics, Bulkamid
Medtronic, INC. $5,346.77 2021-2025 Interstim, Altaviva
Medtronic USA, INC. $3,539.24 2019-2020
Astellas Pharma US INC $481.66 2019-2021
Abbvie INC. $442.29 2020-2025 Lupron Depot, Botox
Boston Scientific Corporation $439.03 2019-2025 Axonics, Lithovue
Bayer Healthcare Pharmaceuticals INC. $382.89 2019-2024
Valencia Technologies Corporation $328.32 2022-2025 Ecoin Device Kit
Janssen Biotech, INC. $232.96 2020-2024 Akeega, Erleada
Urogen Pharma, INC. $224.06 2021-2025 Jelmyto
Kerecis Limited $224.02 2024 Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose
Coloplast Corp $178.43 2019-2023 Titan
Agiliti Surgical, INC. $161.24 2019
Contura, INC. $145.57 2020
Show all 40 companies
CompanyGeneral paymentsYearsTop products
Ferring Pharmaceuticals INC. $144.79 2019-2020
Dendreon Pharmaceuticals LLC $132.39 2019-2023 Provenge
Bluewind Medical $127.64 2024-2025 Revi
Femselect INC. $108.02 2023 Enplace
Sun Pharmaceutical Industries INC. $102.68 2022
Olympus America INC. $82.58 2024-2025 Itind System
Tolmar Pharmaceuticals, INC. $82.31 2019-2021
Merck Sharp & Dohme LLC $58.83 2020-2024 Keytruda
Innovation Technologies INC $48.20 2022
Travere Therapeutics, INC. $42.81 2019-2020
Allergan, INC. $39.79 2019-2020
Myovant Sciences INC. $33.54 2021-2022
Laborie Medical Technologies Corp. $26.92 2025
Astrazeneca Pharmaceuticals LP $26.40 2022
Amag Pharmaceuticals, INC. $24.50 2019
Covidien LP $23.84 2019
Neotract INC. $19.15 2020
Duchesnay USA Incorporated $18.07 2019
Genzyme Corporation $17.62 2019
Zyla Life Sciences, INC. $17.46 2019
Endo Pharmaceuticals INC. $16.33 2019
Photocure INC $15.62 2024 Cysview
Novartis Pharmaceuticals Corporation $14.58 2019
Antares Pharma, INC. $13.40 2022
Mission Pharmacal Company $12.28 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

Research and ownership

$2,096.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Tracy L Cannon-Smith

$28,878.88

in general payments reported 2019-2025

Years
2019-2025
Top company
Caldera Medical, INC
Context
The $1,394 reported for 2025 was more than what a typical Urogynecology and Reconstructive Pelvic Surgery (Urology) provider received nationally (typical 2025 total: $782).

https://glasscript.com/doctor/314769/tracy-l-cannon-smith

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.